Antituberculosis drug–induced hypersensitivity: clinical characteristics and risk factors
This large cohort study highlights key risk factors and clinical outcomes in tuberculosis drug hypersensitivity. Close monitoring of high-risk patients in the early treatment phase may reduce delays and improve outcomes.
Authors
- Zeynep Yeğin Katran (ORCID: https://orcid.org/0000-0002-6858-6824)
- Fatma Merve Tepetam (ORCID: https://orcid.org/0000-0002-9794-5662)
- İsmet Bulut
- Metin Keren (ORCID: https://orcid.org/0000-0003-1047-4165)
- Aylin Babalık (ORCID: https://orcid.org/0000-0002-4872-1558)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Allergologia et Immunopathologia
- Published
- 2025-09-01
- DOI
- https://doi.org/10.15586/aei.v53i5.1427
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00